Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

5.31
+0.04000.76%
Volume:205.28K
Turnover:1.09M
Market Cap:102.70M
PE:-0.87
High:5.41
Open:5.25
Low:5.17
Close:5.27
52wk High:20.56
52wk Low:5.13
Shares:19.34M
Float Shares:13.25M
Volume Ratio:0.49
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.00
PE(LYR):-0.90

Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Slides 6.6%, Underperforms Peers

Dow Jones
·
Jul 14

Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market

Dow Jones
·
Jul 10

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 09

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 07

Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.d. as Chief Medical Officer

THOMSON REUTERS
·
Jul 06

Press Release: Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer

Dow Jones
·
Jul 06

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 02

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 30

Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.9%, Outperforms Peers

Dow Jones
·
Jun 27

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 24

Corbus Pharmaceuticals price target lowered to $34 from $44 at Mizuho

TIPRANKS
·
Jun 24

Mizuho Securities Cuts Price Target on Corbus Pharmaceuticals to $34 From $44, Maintains Outperform Rating

MT Newswires Live
·
Jun 23

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 19

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Jun 18

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 18

Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $52 From $54, Maintains Outperform Rating

MT Newswires Live
·
Jun 17

Corbus Pharmaceuticals Holdings : Oppenheimer Cuts Target Price to $52 From $54

THOMSON REUTERS
·
Jun 17

Corbus Pharmaceuticals Holdings Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Jun 16

Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market

Dow Jones
·
Jun 12

Corbus Pharma director Winston Kung reports disposal of 2,026 common shares worth $16,026.85

Reuters
·
Jun 12